This time around, Lyri­ca's in­ven­tor is de­vel­op­ing his North­west­ern dis­cov­er­ies at his own biotech

Richard Sil­ver­man was left in the dark for the last five years of clin­i­cal de­vel­op­ment of the drug he dis­cov­ered. The North­west­ern Uni­ver­si­ty pro­fes­sor found …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER